WASHINGTON— Federal health regulators have approved an attention deficit disorder drug for a new use: A first-of-its kind treatment for binge-eating disorder. About 2 percent of U.S. adults, or about 5 million people, have binge eating disorder, according to the Department of Health and Human Services. The Food and Drug Administration originally approved...» Read More
Fresh off winning the NBA title with the Miami Heat, hoops legend Ray Allen is driving the lanes of Congress, asking for multi-year funding of diabetes research.
A man dubbed the "Godfather of Heroin" and slapped with sanctions for allegedly helping prop up Myanmar's brutal former military junta through illegal business dealings died.
The U.K.'s energy regulator proposed new rules to combat electricity theft, revealing that up to one-third of electricity stolen each year is used to power cannabis farms.
Andrea Sanderlin of Scarsdale, New York, has been indicted for manufacturing and possessing marijuana with intent to distribute. CNBC's Andrea Day has the details.
A Supreme Court decision gives the FTC the go-ahead to continue suing drug makers over deals that delay generic versions from being sold.
The Supreme Court says deals between pharmaceutical companies and their generic drug competitors can sometimes be illegal.
A Westchester County, New York, woman is accused of running a massive pot operation, reports NBC's Andrea Day. And lobbying efforts to legalize some aspects of the marijuana business are making a pitch to lawmakers, reports CNBC's Hampton Pearson.
Andrea Sanderlin of Scarsdale, NY, has been accused of running a massive pot operation, reports NBC's Andrea Day.
Government officials, drug companies and medical experts, faced with outbreaks of antibiotic-resistant "superbugs", are pushing to speed up the approval of new antibiotics, the NYT reports.
A dispute within the FDA on whether to put new lung-cancer warnings on ARBs taken by millions of people is unlikely to have any significant effect on the manufacturers stocks.
Generic drugmaker Actavis will buy specialty pharmaceuticals company Warner Chilcott in a stock deal valued at about $8.5 billion.
In a first for the drug industry, Pfizer told The Associated Press that the drugmaker will begin selling its popular erectile dysfunction pill Viagra directly to patients on its website.
Federal regulators are pressing the Supreme Court to stop big pharmaceuticals from paying generic drug competitors to delay releasing cheaper versions of brand-name drugs.
Roger Parloff, Fortune senior editor, says businesses are sprouting in states like Colorado and Washington, where selling cannabis is now legal.
What are some of the major seizures and big busts law enforcers have made in recent years? Click on to see 10 cases that were record-breaking, major, or even bizarre in nature.
Emerging markets, and in particular, Latin America will be the drivers for continued growth, Swiss drug maker Roche told CNBC, even as the company faces price pressures elsewhere.
Eli Lilly will be "very challenged" by the loss of exclusivity on several blockbuster drugs, CEO John Lechleiter told CNBC on Tuesday, but added the company can manage its growth in response.
As Christmas overeating gives way to under-fulfilled new year diets, the pharmaceutical industry's appetite has been whetted for a fresh surge in business.
Marijn Dekkers, CEO of Bayer, explains to CNBC that while Bayer has felt increased pressure on drug pricing from governments, its success in research and development has the company positioned for success.
Discounts up to 50 percent discount on premium drugs have been passed on to Medicare beneficiaries.